During the past decade, Instituto Biomedico De Investigacion A.C. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Biomedico De Investigacion A.C." #1 sponsor was "Pfizer" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "CardioKine Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Biomedico De Investigacion A.C." #1 collaborator was "Biogen" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Biomedico De Investigacion A.C." are "Alzheimer Disease" (2 trials), "Cardiovascular Disease" (2 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "B-cell Lymphoma" (1 trials) and "Epilepsies, Partial" (1 trials). Many other conditions were trialed in "Instituto Biomedico De Investigacion A.C." in a lesser frequency.

Most popular intervention types in "Instituto Biomedico De Investigacion A.C." are "Drug" (13 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ocrelizumab" (3 trials), "placebo" (3 trials), "bapineuzumab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Biomedico De Investigacion A.C." are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Biomedico De Investigacion A.C.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Instituto Biomedico De Investigacion A.C., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Biomedico De Investigacion A.C., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".